Barbara Deconinck, Endocrinologie-Diabetologie
0754.795.008 · rovalta.com · 28/09/2026
ACTIVE
Barbara Deconinck, Endocrinologie-Diabetologie
Financial year 2025 · Closed on 31/12/2025
Net result257,8 k €-19,6 %over 1 year
Gross margin354,2 k €-16,5 %over 1 year
Equity6 k €-95,3 %over 1 year
Overview
Identity
Source · BCE/KBOBarbara Deconinck, Endocrinologie-Diabetologie is a Private limited company incorporated in 2020. Its main activity is: Specialist medical practice activities. Its registered office is in Langemark-Poelkapelle.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0754.795.008
- Incorporation
- 24/09/2020
- Legal form
- Private limited company
- Registered office
- Nieuwe Kalsijde 5b
8920 Langemark-Poelkapelle · FlandreSee on map - Contributed capital
- 6 000,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitablePositive cashflowPositive EBITDA
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 354,2 k € | -16.5% | 424,1 k € | +9.5% | 387,3 k € | +1.6% | 381,4 k € | +8.3% | 352,1 k € |
| EBITDA | 352,1 k € | -16.9% | 423,5 k € | +9.5% | 386,8 k € | +1.4% | 381,3 k € | +8.3% | 352 k € |
| Operating result | 341 k € | -19.3% | 422,3 k € | +9.3% | 386,5 k € | +1.6% | 380,4 k € | +8.3% | 351,1 k € |
| Net result | 257,8 k € | -19.6% | 320,5 k € | +9.0% | 294 k € | +1.4% | 289,9 k € | +8.3% | 267,8 k € |
| Balance sheet | |||||||||
| Equity | 6 k € | -95.3% | 126,5 k € | +26.6% | 100 k € | -87.6% | 807,5 k € | +56.0% | 517,7 k € |
| Total assets | 287,5 k € | -17.4% | 348,2 k € | +10.5% | 315,2 k € | -61.0% | 808,4 k € | +54.8% | 522,2 k € |
| Cash | 41,6 k € | -57.2% | 97 k € | +245% | 28,1 k € | -95.3% | 596 k € | +71.1% | 348,4 k € |
| Debts | 281,5 k € | +27.0% | 221,6 k € | +3.0% | 215,2 k € | +24239% | 884,3 € | -80.5% | 4,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Barbara Deconinck | Directorsince 17/09/2020 |
Other companies at this address
Nieuwe Kalsijde 5b 8920 Langemark-Poelkapelle| Company | CBE no. |
|---|---|
ERARD VERZEKERINGEN● Active | 0434.821.504 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 17/09/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 4 months |
| Filing date | 31/08/2026 | 29/08/2025 | 31/07/2024 | 31/07/2023 | 30/08/2022 | 31/08/2021 |
| General meeting | 08/05/2026 | 09/05/2025 | 10/05/2024 | 12/05/2023 | 13/05/2022 | 14/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 08/05/2026 | 31/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 09/05/2025 | 29/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 10/05/2024 | 31/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 12/05/2023 | 31/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 13/05/2022 | 30/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 14/05/2021 | 31/08/2021 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Barbara Deconinck | Directorsince 17/09/2020 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other28/09/2020RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings6 filings
Mandates
Barbara Deconinck
2020202120222023202420252026
Barbara Deconinck, Endocrinologie-Diabetologie
Nieuwe Kalsijde 5 bte B, 8920 Langemark-Poelkapelle
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Nieuwe Kalsijde 5b, 8920 Langemark-PoelkapelleCurrent | CBE | |
| Nieuwe Kalsijde 5 bte B, 8920 Langemark-Poelkapelle | accounts 2021 → 2025 | Accounts 2025 · 2026-00506342 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Barbara Deconinck, Endocrinologie-DiabetologieCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00506342 |
Events
- 2025Annual accounts 2025257,8 k €↓
- 2024Annual accounts 2024320,5 k €↑
- 2023Annual accounts 2023294 k €↑
- 2022Annual accounts 2022289,9 k €↑
- 2021Annual accounts 2021267,8 k €↑
- 2020Annual accounts 2020243,9 k €
- 24/09/2020IncorporationPrivate limited company